Aug. 30, 2022
by Andrii Buvailo
Biopharma insight
Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related …
July 14, 2023
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
Feb. 21, 2024
by BiopharmaTrend
News
Insilico Medicine, a leader in AI-driven drug discovery, has developed a new preclinical candidate, ISM9682, aimed at treating advanced solid …
Feb. 21, 2024
by BiopharmaTrend
News
Absci has embarked on IND-enabling studies for ABS-101, an anti-TL1A antibody, leveraging its generative AI technology to streamline the development …
Oct. 18, 2022
by Andrii Buvailo
Biopharma insight
Proteins are essential components of living matter — they function as building blocks for cells and tissues, as well as …
Nov. 6, 2022
by Andrii Buvailo
Interview
While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker …
Oct. 6, 2021
by Andrii Buvailo
Biopharma insight
Disclaimer: This post is not medical advice, it is only for informational purposes. In case of need, consult your doctor …
Feb. 4, 2023
by Andrii Buvailo
Biopharma insight
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
Sept. 3, 2023
by Andrii Buvailo
Interview
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …
Jan. 12, 2024
by Andrii Buvailo
News
Verge Genomics, a clinical-stage biotechnology company, has just initiated a Phase 1b proof-of-concept study for VRG50635, a drug developed for …
May 31, 2022
by Chris De Savi
Biopharma insight
The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …